P-167 - Efficacy and tolerance of XELOX plus bevacizumab as first line therapy in Moroccan patients with metastatic colorectal cancer

Autor: Mahfoud, Tarik, Khmamouche, Mohamed Réda, Tanz, Rachid, Errihani, Hassan, Ichou, Mohamed
Zdroj: In Annals of Oncology June 2017 28 Supplement 3:iii62-iii62
Databáze: ScienceDirect